Contractor
RAFA LABORATORIES LTD
JERUSALEM
- UEI
- CKDNTKNDPMJ6
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$45,390,6991
Awards
2
Agencies served
1
Active from Sep 30, 2025 to Aug 10, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50125C00018 THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES THE FOLLOWING DEVELOPMENT ESSENTIALS: CMC DEVELOPMENT, PRE-CLINICAL AND CLINICAL STUDIES, DEVICE DEVELOPMENT ACTIVITIES, HUMAN FACTORS TESTING, MARKET VIABILITY ASSESSMENTS ALONG WITH ALL ASSOCIATED REGULA | Department of Health and Human Services | — | Sep 30, 2025 | $11,997,762 |
| 75A50325C00020 RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG) | Department of Health and Human Services | — | Sep 30, 2025 | $33,392,937 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier CKDNTKNDPMJ6, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 24, 2026.